Status:
COMPLETED
Effects of a Rheumatoid Arthritis Self-management Program
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Arthritis, Rheumatoid
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Rheumatoid arthritis (RA) is a persistent systemic disease. WHO (World Health Organization) commented that a crucial goal of heath care for RA is prevention of loss of daily function by patients' self...
Detailed Description
Rheumatoid arthritis (RA) is a persistent systemic disease. WHO (World Health Organization) commented that a crucial goal of heath care for RA is prevention of loss of daily function by patients' self...
Eligibility Criteria
Inclusion
- Diagnosed with RA
- Age of 20 years or over
- Disease considered have been stable for at least 3 months
- Able to understand and comply with the study treatment
Exclusion
- Suffering from other terminal illnesses, severe dementia or another debilitating psychiatric disorder
- Living in a long-term care facility
- Participation in another research protocol
Key Trial Info
Start Date :
September 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2018
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT03470740
Start Date
September 1 2016
End Date
July 31 2018
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taoyuan District, Taiwan, 33303